Delivery Order SPE2DR25D9223-SPE2DR26FFAC8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,936.30 to DMS Pharmaceutical Group Inc. for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. The contract, finalized on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a continuation of the company's substantial role as a prime vendor within the DLA's pharmaceutical supply network. The award carries no set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $5,795.49 from the Defense Logistics Agency on December 2, 2025. This firm fixed-price delivery order, which has no set-aside designation, represents one of numerous orders issued to the contractor under its larger Indefinite Delivery Contract with the DLA. The contract authorizes the issuance of delivery orders for pharmaceutical products,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,264.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 10, 2025, represents one of multiple orders issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) established through the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $11,829.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a single award with no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group...
- This delivery order, valued at $5,249.03, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order under the DLA's pharmaceutical prime vendor fleet program. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order valued at $5,170.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded on August 15, 2025, with an ultimate completion date of September 8, 2025, is issued under the company's larger Indefinite Delivery Contract with DLA valued at $499.99 million and valid through November 2026. The delivery order employs firm fixed-price pricing and carries no...
- The Defense Logistics Agency (DLA) under the Medical Supply Chain program awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 22, 2025, with an ultimate completion date of September 24, 2025, carries no set-aside designation. The award represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,072.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 20, 2025. This firm fixed-price delivery order covers the supply of Livdelzi 10 mg capsules (30-count units) with an ultimate completion date of September 11, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned...
- The Defense Logistics Agency issued a delivery order valued at $49,224.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a specific issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract contains no set-aside designation, allowing the vendor to compete...
- SPE2DR25D9223Indefinite Delivery Contract
- SPE2DR25D9223-SPE2DR26FFAC8Delivery Order
The Defense Logistics Agency (DLA) issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 90 tablets of Letrozole 2.5 mg with a ceiling value of $1,047.30. This firm fixed-price delivery order was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and carries no set-aside designation. The order will be fulfilled at the contractor's Park Ridge facility and represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy. The company's prime vendor contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity with numerous delivery orders since October 2025, establishing itself as a competitive pharmaceutical supplier capable of meeting diverse and specialized requirements of the military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/10/25 |